A biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Oncology Biomarker industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Lung Cancer
Breast Cancer
Colorectal Cancer
Prostate Cancer
Stomach Cancer
Others
Market Segment by Product Application
Diagnostics
Drug Discovery And Development
Prognostics
Risk Assessment
Others
Finally, the report provides detailed profile and data information analysis of leading company.
Abbott Laboratories
Bristol-Myers Squibb
Eli Lilly and Company
F.Hoffmann-La Roche Ltd.
Genomic Health
GlaxoSmithKline plc
Novartis AG
Merck & Co.
Pfizer
Qiagen N.V.
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Oncology Biomarker consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Oncology Biomarker market by identifying its various subsegments.
3.Focuses on the key global Oncology Biomarker manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Oncology Biomarker with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Oncology Biomarker submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Oncology Biomarker Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Oncology Biomarker Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Oncology Biomarker Segment by Type
2.1.1 Lung Cancer
2.1.2 Breast Cancer
2.1.3 Colorectal Cancer
2.1.4 Prostate Cancer
2.1.5 Stomach Cancer
2.1.6 Others
2.2 Market Analysis by Application
2.2.1 Diagnostics
2.2.2 Drug Discovery And Development
2.2.3 Prognostics
2.2.4 Risk Assessment
2.2.5 Others
2.3 Global Oncology Biomarker Market Comparison by Regions (2017-2027)
2.3.1 Global Oncology Biomarker Market Size (2017-2027)
2.3.2 North America Oncology Biomarker Status and Prospect (2017-2027)
2.3.3 Europe Oncology Biomarker Status and Prospect (2017-2027)
2.3.4 China Oncology Biomarker Status and Prospect (2017-2027)
2.3.5 Japan Oncology Biomarker Status and Prospect (2017-2027)
2.3.6 Southeast Asia Oncology Biomarker Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Oncology Biomarker Industry Impact
2.5.1 Oncology Biomarker Business Impact Assessment - Covid-19
2.5.2 Market Trends and Oncology Biomarker Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Oncology Biomarker Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Oncology Biomarker Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Oncology Biomarker Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Oncology Biomarker Manufacturer Market Share
3.5 Top 10 Oncology Biomarker Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Oncology Biomarker Market
3.7 Key Manufacturers Oncology Biomarker Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Oncology Biomarker Industry Key Manufacturers
4.1 Abbott Laboratories
4.1.1 Compan Detail
4.1.2 Abbott Laboratories Oncology Biomarker Product Introduction, Application and Specification
4.1.3 Abbott Laboratories 134 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Abbott Laboratories News
4.2 Bristol-Myers Squibb
4.2.1 Compan Detail
4.2.2 Bristol-Myers Squibb Oncology Biomarker Product Introduction, Application and Specification
4.2.3 Bristol-Myers Squibb Oncology Biomarker Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Abbott Laboratories News
4.3 Eli Lilly and Company
4.3.1 Compan Detail
4.3.2 Eli Lilly and Company Oncology Biomarker Product Introduction, Application and Specification
4.3.3 Eli Lilly and Company Oncology Biomarker Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Eli Lilly and Company News
4.4 F.Hoffmann-La Roche Ltd.
4.4.1 Compan Detail
4.4.2 F.Hoffmann-La Roche Ltd. Oncology Biomarker Product Introduction, Application and Specification
4.4.3 F.Hoffmann-La Roche Ltd. Oncology Biomarker Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 F.Hoffmann-La Roche Ltd. News
4.5 Genomic Health
4.5.1 Compan Detail
4.5.2 F.Hoffmann-La Roche Ltd. Oncology Biomarker Product Introduction, Application and Specification
4.5.3 Genomic Health Oncology Biomarker Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Genomic Health News
4.6 GlaxoSmithKline plc
4.6.1 Compan Detail
4.6.2 GlaxoSmithKline plc Oncology Biomarker Product Introduction, Application and Specification
4.6.3 GlaxoSmithKline plc Oncology Biomarker Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 GlaxoSmithKline plc News
4.7 Novartis AG
4.7.1 Compan Detail
4.7.2 Novartis AG Oncology Biomarker Product Introduction, Application and Specification
4.7.3 Novartis AG Oncology Biomarker Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Merck & Co.
4.8.1 Compan Detail
4.8.2 Merck & Co. Oncology Biomarker Product Introduction, Application and Specification
4.8.3 Merck & Co. Oncology Biomarker Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Merck & Co. News
4.9 Pfizer
4.9.1 Compan Detail
4.9.2 Pfizer Oncology Biomarker Product Introduction, Application and Specification
4.9.3 Pfizer Oncology Biomarker Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Pfizer News
4.10 Qiagen N.V.
4.10.1 Compan Detail
4.10.2 Qiagen N.V. Oncology Biomarker Product Introduction, Application and Specification
4.10.3 Qiagen N.V. Oncology Biomarker Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Qiagen N.V. News
5 Global Oncology Biomarker Market Segment by Big Type
5.1 Global Oncology Biomarker Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Oncology Biomarker Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Oncology Biomarker Revenue and Market Share by Big Type (2017-2022)
5.2 Lung Cancer Sales Growth Rate and Price
5.2.1 Global Lung Cancer Sales Growth Rate (2017-2022)
5.2.2 Global Lung Cancer Price (2017-2022)
5.3 Breast Cancer Sales Growth Rate and Price
5.3.1 Global Breast Cancer Sales Growth Rate (2017-2022)
5.3.2 Global Breast Cancer Price (2017-2022)
5.4 Colorectal Cancer Sales Growth Rate and Price
5.4.1 Global Colorectal Cancer Sales Growth Rate (2017-2022)
5.4.2 Global Colorectal Cancer Price (2017-2022)
5.5 Prostate Cancer Sales Growth Rate and Price
5.5.1 Global Prostate Cancer Sales Growth Rate (2017-2022)
5.5.2 Global Prostate Cancer Price (2017-2022)
5.6 Stomach Cancer Sales Growth Rate and Price
5.6.1 Global Stomach Cancer Sales Growth Rate (2017-2022)
5.6.2 Global Stomach Cancer Price (2017-2022)
5.7 Others Sales Growth Rate and Price
5.7.1 Global Others Sales Growth Rate (2017-2022)
5.7.2 Global Others Price (2017-2022)
6 Global Oncology Biomarker Market Segment by Big Application
6.1 Global Oncology Biomarker Sales Market Share by Big Application (2017-2022)
6.2 Diagnostics Sales Growth Rate (2017-2022)
6.3 Drug Discovery And Development Sales Growth Rate (2017-2022)
6.4 Prognostics Sales Growth Rate (2017-2022)
6.5 Risk Assessment Sales Growth Rate (2017-2022)
6.6 Others Sales Growth Rate (2017-2022)
7 Global Oncology Biomarker Forecast
7.1 Global Oncology Biomarker Revenue, Sales and Growth Rate (2022-2027)
7.2 Oncology Biomarker Market Forecast by Regions (2022-2027)
7.2.1 North America Oncology Biomarker Market Forecast (2022-2027)
7.2.2 Europe Oncology Biomarker Market Forecast (2022-2027)
7.2.3 China Oncology Biomarker Market Forecast (2022-2027)
7.2.4 Japan Oncology Biomarker Market Forecast (2022-2027)
7.2.5 Southeast Asia Oncology Biomarker Market Forecast (2022-2027)
7.2.6 Other Regions Oncology Biomarker Market Forecast (2022-2027)
7.3 Oncology Biomarker Market Forecast by Type (2022-2027)
7.3.1 Global Oncology Biomarker Sales Forecast by Type (2022-2027)
7.3.2 Global Oncology Biomarker Market Share Forecast by Type (2022-2027)
7.4 Oncology Biomarker Market Forecast by Application (2022-2027)
7.4.1 Global Oncology Biomarker Sales Forecast by Application (2022-2027)
7.4.2 Global Oncology Biomarker Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Oncology Biomarker Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Oncology Biomarker Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Oncology Biomarker
Figure Market Concentration Ratio and Market Maturity Analysis of Oncology Biomarker
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Oncology Biomarker Market Size by Big Type
Figure Global Market Share of Oncology Biomarker by Big Type in 2021
Figure Lung Cancer Picture (2017-2022)
Figure Breast Cancer Picture (2017-2022)
Figure Colorectal Cancer Picture (2017-2022)
Figure Prostate Cancer Picture (2017-2022)
Figure Stomach Cancer Picture (2017-2022)
Global Oncology Biomarker Market Size by Big Application
Table Global Oncology Biomarker Market Size by Application
Figure Global Oncology Biomarker Market Share by Big Application in 2021
Figure Diagnostics Picture
Figure Drug Discovery And Development Picture
Figure Prognostics Picture
Figure Risk Assessment Picture
Figure Others Picture
Table Global Oncology Biomarker Comparison by Regions (M USD) (2017-2027)
Figure Global Oncology Biomarker Market Size (Million US$) (2017-2027)
Figure North America Oncology Biomarker Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Oncology Biomarker Revenue (Million US$) Growth Rate (2017-2027)
Figure China Oncology Biomarker Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Oncology Biomarker Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Oncology Biomarker Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Oncology Biomarker Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Oncology Biomarker Sales by Manufacturer (2017-2022)
Figure Global Oncology Biomarker Sales Market Share by Manufacturer in 2021
Table Global Oncology Biomarker Revenue by Manufacturer (2017-2022)
Figure Global Oncology Biomarker Revenue Market Share by Manufacturer in 2021
Table Global Oncology Biomarker Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Oncology Biomarker Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Oncology Biomarker Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Oncology Biomarker Market
Table Key Manufacturers Oncology Biomarker Product Type
Table Mergers & Acquisitions Planning
Table Abbott Laboratories Company Profile
Table Oncology Biomarker Product Introduction, Application and Specification of Abbott Laboratories
Table Oncology Biomarker Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Bristol-Myers Squibb Company Profile
Table Oncology Biomarker Product Introduction, Application and Specification of Bristol-Myers Squibb
Table Oncology Biomarker Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bristol-Myers Squibb Recent Development
Table Eli Lilly and Company Company Profile
Table Oncology Biomarker Product Introduction, Application and Specification of Eli Lilly and Company
Table Oncology Biomarker Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Eli Lilly and Company Main Business
Table Eli Lilly and Company Recent Development
Table F.Hoffmann-La Roche Ltd. Company Profile
Table Oncology Biomarker Product Introduction, Application and Specification of F.Hoffmann-La Roche Ltd.
Table Oncology Biomarker Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table F.Hoffmann-La Roche Ltd. Main Business
Table F.Hoffmann-La Roche Ltd. Recent Development
Table F.Hoffmann-La Roche Ltd. Main Business
Table F.Hoffmann-La Roche Ltd. Recent Development
Table Genomic Health Company Profile
Table Oncology Biomarker Product Introduction, Application and Specification of Genomic Health
Table Oncology Biomarker Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Genomic Health Main Business
Table Genomic Health Recent Development
Table GlaxoSmithKline plc Company Profile
Table Oncology Biomarker Product Introduction, Application and Specification of GlaxoSmithKline plc
Table Oncology Biomarker Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table GlaxoSmithKline plc Main Business
Table GlaxoSmithKline plc Recent Development
Table Novartis AG Company Profile
Table Oncology Biomarker Product Introduction, Application and Specification of Novartis AG
Table Oncology Biomarker Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Novartis AG Main Business
Table Novartis AG Recent Development
Table Merck & Co. Company Profile
Table Oncology Biomarker Product Introduction, Application and Specification of Merck & Co.
Table Oncology Biomarker Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Merck & Co. Main Business
Table Merck & Co. Recent Development
Table Pfizer Company Profile
Table Oncology Biomarker Product Introduction, Application and Specification of Pfizer
Table Oncology Biomarker Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Pfizer Main Business
Table Pfizer Recent Development
Table Qiagen N.V. Company Profile
Table Oncology Biomarker Product Introduction, Application and Specification of Qiagen N.V.
Table Oncology Biomarker Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Qiagen N.V. Main Business
Table Qiagen N.V. Recent Development
Figure Global Oncology Biomarker Sales and Growth Rate (2017-2022)
Figure Global Oncology Biomarker Revenue and Growth Rate (2017-2022)
Table Global Oncology Biomarker Sales by Regions (2017-2022)
Figure Global Oncology Biomarker Sales Market Share by Regions in 2021
Table Global Oncology Biomarker Revenue by Regions (2017-2022)
Figure Global Oncology Biomarker Revenue Market Share by Regions in 2021
Figure North America Oncology Biomarker Sales and Growth Rate (2017-2022)
Figure Europe Oncology Biomarker Sales and Growth Rate (2017-2022)
Figure China Oncology Biomarker Sales and Growth Rate (2017-2022)
Figure Japan Oncology Biomarker Sales and Growth Rate (2017-2022)
Figure Southeast Asia Oncology Biomarker Sales and Growth Rate (2017-2022)
Figure Other Regions Oncology Biomarker Sales and Growth Rate (2017-2022)
Table Global Oncology Biomarker Sales by Big Type (2017-2022)
Table Global Oncology Biomarker Sales Market Share by Big Type (2017-2022)
Figure Global Oncology Biomarker Sales Market Share by Big Type in 2019
Table Global Oncology Biomarker Revenue by Big Type (2017-2022)
Table Global Oncology Biomarker Revenue Market Share by Big Type (2017-2022)
Table Global Oncology Biomarker Revenue Market Share by Big Type in 2019
Figure Global Lung Cancer Sales Growth Rate (2017-2022)
Figure Global Lung Cancer Price (2017-2022)
Figure Global Breast Cancer Sales Growth Rate (2017-2022)
Figure Global Breast Cancer Price (2017-2022)
Figure Global Colorectal Cancer Sales Growth Rate (2017-2022)
Figure Global Colorectal Cancer Price (2017-2022)
Figure Global Prostate Cancer Sales Growth Rate (2017-2022)
Figure Global Prostate Cancer Price (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Table Global Oncology Biomarker Sales by Big Application (2017-2022)
Table Global Oncology Biomarker Sales Market Share by Big Application (2017-2022)
Figure Global Oncology Biomarker Sales Market Share by Big Application in 2019
Figure Global Diagnostics Sales Growth Rate (2017-2022)
Figure Global Drug Discovery And Development Sales Growth Rate (2017-2022)
Figure Global Prognostics Sales Growth Rate (2017-2022)
Figure Global Risk Assessment Sales Growth Rate (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Figure Global Oncology Biomarker Sales and Growth Rate (2022-2027)
Figure Global Oncology Biomarker Revenue and Growth Rate (2022-2027)
Table Global Oncology Biomarker Sales Forecast by Regions (2022-2027)
Table Global Oncology Biomarker Market Share Forecast by Regions (2022-2027)
Figure North America Sales Oncology Biomarker Market Forecast (2022-2027)
Figure Europe Sales Oncology Biomarker Market Forecast (2022-2027)
Figure China Sales Oncology Biomarker Market Forecast (2022-2027)
Figure Japan Sales Oncology Biomarker Market Forecast (2022-2027)
Figure Southeast Asia Sales Oncology Biomarker Market Forecast (2022-2027)
Figure Other Regions Sales Oncology Biomarker Market Forecast (2022-2027)
Table Global Oncology Biomarker Sales Forecast by Type (2022-2027)
Table Global Oncology Biomarker Market Share Forecast by Type (2022-2027)
Table Global Oncology Biomarker Sales Forecast by Application (2022-2027)
Table Global Oncology Biomarker Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology Biomarker
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Oncology Biomarker Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Oncology Biomarker Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Oncology Biomarker Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Oncology Biomarker Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Oncology Biomarker Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Oncology Biomarker Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Oncology Biomarker Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Oncology Biomarker Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Abbott Laboratories
Bristol-Myers Squibb
Eli Lilly and Company
F.Hoffmann-La Roche Ltd.
Genomic Health
GlaxoSmithKline plc
Novartis AG
Merck & Co.
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)